Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LEONARD H CALABRESE

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1467415265
CMS profile
65714
Location
CLEVELAND, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$250,872.06

185 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $76,216.56 68
GENZYME CORPORATION $52,575.88 26
GlaxoSmithKline, LLC. $35,770.68 7
Amgen Inc. $27,476.10 31
UCB, Inc. $19,270.02 25
Janssen Biotech, Inc. $16,270.60 16
E.R. Squibb & Sons, L.L.C. $14,850.00 5
PFIZER INC. $6,750.00 1
Janssen Scientific Affairs, LLC $1,585.53 2
Gilead Sciences, Inc. $55.03 2
AstraZeneca UK Limited $38.00 1
Lilly USA, LLC $13.66 1

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

185 matching records · $250,872.06 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 185 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 185.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $1,050.0012/18/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016029161 CMS
Gilead Sciences, Inc. $40.1212/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025537555 CMS
GlaxoSmithKline, LLC. $1,462.4812/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003512941 CMS
GlaxoSmithKline, LLC. $5,200.0012/15/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003512945 CMS
GlaxoSmithKline, LLC. $387.0012/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003512951 CMS
GlaxoSmithKline, LLC. $5,200.0012/15/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003512955 CMS
GlaxoSmithKline, LLC. $20.0012/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003512967 CMS
Janssen Scientific Affairs, LLC $1,575.0012/11/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988525809 CMS
Amgen Inc. $2,775.0011/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020819201 CMS
AstraZeneca Pharmaceuticals LP $46.8511/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014250721 CMS
Lilly USA, LLC $13.6611/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061276697 CMS
AstraZeneca Pharmaceuticals LP $268.5011/10/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014132551 CMS
Amgen Inc. $1,150.0011/08/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020623497 CMS
Janssen Biotech, Inc. $1,100.0011/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988391673 CMS
Amgen Inc. $209.4310/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020623493 CMS
Amgen Inc. $9.0910/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020623495 CMS
AstraZeneca Pharmaceuticals LP $1,050.0010/27/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011770613 CMS
Amgen Inc. $3,330.0010/23/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020623501 CMS
Amgen Inc. $1,110.0010/23/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020623503 CMS
Amgen Inc. $176.3210/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020623505 CMS
Amgen Inc. $145.3610/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020000001 CMS
Amgen Inc. $122.4510/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020623499 CMS
Amgen Inc. $1,454.6910/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020819197 CMS
AstraZeneca Pharmaceuticals LP $2,685.0010/06/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016192161 CMS
Amgen Inc. $3,330.0010/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020819193 CMS
Amgen Inc. $555.0010/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020819195 CMS
Amgen Inc. $96.5609/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020819191 CMS
AstraZeneca Pharmaceuticals LP $4,300.0009/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011319343 CMS
Amgen Inc. $1,824.0009/13/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020623489 CMS
Amgen Inc. $608.0009/13/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020623491 CMS
GENZYME CORPORATION $80.2409/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049650153 CMS
GENZYME CORPORATION $2,916.0009/05/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049650165 CMS
GENZYME CORPORATION $554.2409/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049650171 CMS
GENZYME CORPORATION $342.0009/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049650177 CMS
GENZYME CORPORATION $6,804.0009/05/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049650183 CMS
GENZYME CORPORATION $505.7309/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049650189 CMS
GENZYME CORPORATION $346.5009/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049650195 CMS
AstraZeneca Pharmaceuticals LP $201.1908/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014430461 CMS
AstraZeneca Pharmaceuticals LP $678.6208/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015396421 CMS
AstraZeneca Pharmaceuticals LP $112.2308/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015599547 CMS
AstraZeneca Pharmaceuticals LP $1,050.0008/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011595661 CMS
Janssen Biotech, Inc. $3,850.0008/26/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988391603 CMS
Janssen Biotech, Inc. $2,475.0008/26/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988391655 CMS
AstraZeneca Pharmaceuticals LP $1,050.0008/24/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014388981 CMS
AstraZeneca Pharmaceuticals LP $1,050.0008/24/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015891787 CMS
AstraZeneca Pharmaceuticals LP $2,148.0008/24/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016028878 CMS
Janssen Biotech, Inc. $848.2808/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988391663 CMS
AstraZeneca Pharmaceuticals LP $1,050.0008/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015997903 CMS
Janssen Biotech, Inc. $121.8608/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988391613 CMS
Janssen Biotech, Inc. $647.8008/22/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988391623 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $335,502.75 286
PY2020 $244,707.50 150
PY2021 $210,188.31 147
PY2022 $316,455.15 245
PY2023 $250,872.06 185
PY2024 $259,438.50 184
PY2025 $294,074.30 214

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
LEONARD H CALABRESE, NPI 1467415265. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1467415265.
APA 7
IndustryPayments. (2026). LEONARD H CALABRESE, NPI 1467415265 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1467415265
Bluebook
LEONARD H CALABRESE, NPI 1467415265, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1467415265.

Source: Centers for Medicare & Medicaid Services, Open Payments.